日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore

新加坡接种三剂BNT162b2 mRNA新冠疫苗90天后SARS-CoV-2刺突蛋白和中和抗体动力学研究

Lau, Chin Shern; Phua, Soon Kieng; Liang, Ya Li; Oh, May Lin Helen; Aw, Tar Choon

210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine

BNT162b2 mRNA疫苗3剂疗程中总抗体、IgG抗体和中和刺突抗体的210天动力学

Lau, Chin Shern; Oh, May Lin Helen; Phua, Soon Kieng; Liang, Ya-Li; Aw, Tar Choon

Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore

新加坡受试者接种科兴灭活病毒疫苗后,中和抗体和刺突蛋白SARS-CoV-2抗体的动力学与辉瑞mRNA疫苗的比较

Lau, Chin Shern; Oh, May Lin Helen; Phua, Soon Kieng; Liang, Ya Li; Li, Yanfeng; Huo, Jianxin; Huang, Yuhan; Zhang, Biyan; Xu, Shengli; Aw, Tar Choon

Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster

接种同源CoronaVac疫苗与BNT162b2疫苗后,加强免疫后90天内中和抗体和总/IgG刺突抗体反应的比较

Lau, Chin Shern; Thundyil, John; Oh, May Lin Helen; Phua, Soon Kieng; Liang, Ya Li; Li, Yanfeng; Huo, Jianxin; Huang, Yuhan; Zhang, Biyan; Xu, Shengli; Aw, Tar Choon

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial

在新加坡完成四价登革热疫苗基础免疫5年以上后,接种加强剂的体液和细胞免疫原性及安全性:一项随机II期安慰剂对照试验的2年随访结果

Park, Juliana; Archuleta, Sophia; Oh, May-Lin Helen; Shek, Lynette Pei-Chi; Wang, Hao; Bonaparte, Matthew; Frago, Carina; Bouckenooghe, Alain; Jantet-Blaudez, Frederique; Begue, Sarah; Gimenez-Fourage, Sophie; Pagnon, Anke

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series

新加坡登革热疫苗加强针的免疫原性和安全性:一项随机II期安慰剂对照试验,评估其在完成基础免疫接种5-6年后的效果

Park, Juliana; Archuleta, Sophia; Oh, May-Lin Helen; Shek, Lynette Pei-Chi; Jin, Jing; Bonaparte, Matthew; Fargo, Carina; Bouckenooghe, Alain